| Q40886461 | Abl tyrosine kinase in signal transduction and cell-cycle regulation |
| Q28776768 | Alphaherpesvirus origin-binding protein homolog encoded by human herpesvirus 6B, a betaherpesvirus, binds to nucleotide sequences that are similar to ori regions of alphaherpesviruses |
| Q38354181 | An activating mutation in the ATP binding site of the ABL kinase domain. |
| Q35166848 | Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies |
| Q74432787 | Determination of the human c-Abl consensus DNA binding site |
| Q52393352 | Downregulation of phospho-tyrosine phosphatases in a macrophage tumor. |
| Q34293368 | Enhancer I predominance in hepatitis B virus gene expression |
| Q41659051 | Functional role for the c-Abl protein tyrosine kinase in the cellular response to genotoxic stress |
| Q73283449 | HBV transcription repression in response to genotoxic stress is p53-dependent and abrogated by pX |
| Q42834308 | Identification of the transcription termination site of the mouse nkx-1.2 gene: involvement of sequence-specific factors |
| Q35868069 | Interactions of the transcription factors MIBP1 and RFX1 with the EP element of the hepatitis B virus enhancer. |
| Q95825937 | Leukoregulin induction of prostaglandin-endoperoxide H synthase-2 in human orbital fibroblasts. An in vitro model for connective tissue inflammation |
| Q34246740 | Molecular biology of chronic myeloid leukemia |
| Q36695729 | Oncogenic activation of c-ABL by mutation within its last exon. |
| Q36686165 | Physical and functional characterization of transcriptional control elements in the equine infectious anemia virus promoter |
| Q24629643 | RFX1 is identical to enhancer factor C and functions as a transactivator of the hepatitis B virus enhancer |
| Q41679375 | Signal transduction by wild-type and leukemogenic Abl proteins. |
| Q40305409 | Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation |
| Q28216325 | The RFX family interacts at the collagen (COL1A2) start site and represses transcription |
| Q37013896 | The c-myc promoter: still MysterY and challenge |
| Q28508496 | The cytostatic function of c-Abl is controlled by multiple nuclear localization signals and requires the p53 and Rb tumor suppressor gene products |
| Q36377421 | The regulation of transcription by phosphorylation |
| Q24301273 | The role of protein-tyrosine phosphatase 1B in integrin signaling |
| Q39453564 | The transcriptional activation and repression domains of RFX1, a context-dependent regulator, can mutually neutralize their activities |
| Q34772795 | Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter |
| Q28138395 | c-Abl: activation and nuclear targets |
| Q40943786 | c-Myb protein binds to the EP element of the HBV enhancer and regulates transcription in synergy with NF-M. |
| Q37693480 | p140/c-Abl that binds DNA is preferentially phosphorylated at tyrosine residues |
| Q33888115 | p53 binds and represses the HBV enhancer: an adjacent enhancer element can reverse the transcription effect of p53 |